Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy

NCT06072573 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

558

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain
Pain Syndrome
Pain, Chronic
Chronic Pain
Chronic Pain Syndrome
Diabetes
Diabetic Neuropathies
Diabetic Polyneuropathy
Peripheral Neuralgia
Peripheral Neuropathy
Peripheral Neuropathy With Type 2 Diabetis

Interventions

DRUG: Adezunap (AP707)
DRUG: Placebo

Sponsor

Apurano Pharmaceuticals GmbH